Skillman, NJ, United States of America

Lalgudi S Harikrishnan

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Princeton, NJ (US) (2006 - 2014)
  • Skillman, NJ (US) (2013 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: **Lalgudi S Harikrishnan: Innovator in Biopharmaceuticals**

Introduction

Lalgudi S Harikrishnan is an esteemed inventor based in Skillman, NJ, who has made significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 19 patents, he has been instrumental in developing novel compounds and therapeutic methods for treating various medical disorders. His work demonstrates a commitment to innovation and a passion for enhancing healthcare solutions.

Latest Patents

Among Lalgudi's latest patents, two stand out for their potential impact on medical treatment. The first is centered around **Agonists of ROR GAMMAt**. This invention is aimed at creating compounds with specific formulas that are beneficial for pharmaceutical compositions and methods for treating diverse disorders. The second patent, **Cyclic dinucleotides as anticancer agents**, similarly focuses on innovative compounds with defined substitutes and their applications in the treatment of various forms of cancer. Both inventions showcase his dedication to advancing medical science and improving patient outcomes.

Career Highlights

Lalgudi S Harikrishnan currently works for Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His position allows him to leverage cutting-edge research and technology to make meaningful advancements in drug development. Over the years, he has played a pivotal role in a variety of projects that have the potential to change the landscape of therapeutic interventions.

Collaborations

Collaboration is key in the world of innovation, and Lalgudi has had the opportunity to work alongside talented colleagues. Notably, he has collaborated with Muthoni G Kamau and Brian E Fink, both of whom contribute their expertise to further enhance the research and development initiatives at Bristol-Myers Squibb. Together, they strive for breakthroughs that can lead to new treatments and improved health outcomes.

Conclusion

Lalgudi S Harikrishnan stands out as a notable inventor in the biopharmaceutical sector, exemplifying innovation through his extensive patent portfolio and collaborative work environment. His latest inventions reflect his commitment to advancing healthcare and his ability to lead groundbreaking research at Bristol-Myers Squibb. As he continues to make strides in his field, Lalgudi remains a vital asset to the community of innovators dedicated to the betterment of human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…